TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
M3 ( (JP:2413) ) has issued an update.
M3, Inc. announced the finalization of terms for the issuance of stock options, as decided in their Board of Directors meeting on August 6, 2025. This move involves the issuance of 782 share acquisition rights, priced at 234,800 yen per right, which translates to 2,348 yen per share. This development is expected to impact the company’s financial operations and could influence its market positioning.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen3000.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, primarily focusing on providing medical-related services and products. The company is listed on the Tokyo Stock Exchange and is headquartered in Tokyo, Japan.
Average Trading Volume: 3,826,198
Technical Sentiment Signal: Hold
Current Market Cap: Yen1581.8B
For an in-depth examination of 2413 stock, go to TipRanks’ Overview page.